|
|
|
|
|
|
|
|
|
|
BMJ
All women in England with ovarian cancer should be tested
for the BRCA1 and BRCA2 mutations at the time of diagnosis, as currently
happens in Scotland, a charity has demanded.
The call by
Ovarian Cancer Action was backed by an expert panel of geneticists,
genetic counsellors, and medical oncologists at a panel discussion held
last week at the Royal Society in London.
The charity’s policy paper calls for all women with invasive non-mucinous epithelial ovarian cancer, …
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.